Thoratec Inactive 10-K2006 FY Annual report

Filed: 2 Apr 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accessory, addressed, adequacy, AMI, Anergen, Antonio, assumption, Avox, AVOXimeter, bedside, behavior, broadly, Caligor, cancelled, CAP, cardiogenic, cardiomyopathy, catherization, CentriMag, Chair, Chiron, classification, clinician, Concept, curve, debenture, deduction, derecognition, durability, eleven, expenditure, extra, Fisher, fourteen, furniture, Genentech, global, graph, Heartware, Henry, hypothetical, ICU, impossible, incumbent, induce, infarction, inhalation, intractable, Jarvik, judgment, lab, land, leader, LLC, mediation, membership, multiplied, neonatal, NICU, nineteen, nitric, oxide, Perlegen, phantom, pharmacologic, pilot, pool, postpartum, premise, procure, puncture, Quantifying, radiation, readily, redefining, redirection, regularly, reinvested, reinvestment, removed, restrospective, retrospective, routine, SAB, San, Schein, shortly, smoke, subscription, tangible, taxation, threshold, traditional, unallocated, unearned, unfavourably, unmet, unrecognized, unrecorded, unregistered, valvular, Vectra, Ventracor, warfarin, yield

Removed: accrual, agency, assembly, Bodycote, buyer, carryforward, conform, connectivity, consistent, Coumadin, decentralization, died, discharged, erosion, experimentation, finalized, formulating, fueled, generating, gradual, interface, investigating, legislative, MacGregor, medication, moderately, negligible, platform, POC, Producing, professional, professionally, ratio, ready, reclassified, REMATCH, restructuring, salary, settle, Sterling, TLC, undergo, virtually, weakening, wear, worked

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Thoratec similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statements on Form S-3 (No. 333-97783, No. 333-72128, No. 333-61136, and No. 333-32684) and Registration Statements on Form S-8 (No. 333-135047, No. 333-106238, 333-90768, 333-80807, 333-56212, 333-32223, 333-11883, 33-35549, 33-72502), Post-Effective Amendment No. 1 to Registration Statement No. 333-90768, Post-Effective Amendment No. 1 to Registration Statement No. 2-97542, Post-Effective Amendment No. 1 to Registration Statement No. 2-78926, and Post-Effective Amendment No. 3 to Registration Statement No. 2-78925, of our report dated March 30, 2007 relating to the financial statements and financial statement schedule of Thoratec Corporation ( which report expresses an unqualified opinion and includes an explanatory paragraph regarding the adoption of Statement of Financial Accounting Standards No. 123(R), “Share-Based Payment”), and our report dated March 30, 2007 relating to management’s report on the effectiveness of internal control over financial reporting, appearing in this Annual Report on Form 10-K of Thoratec Corporation for the year ended December 30, 2006.

/s/ DELOITTE & TOUCHE LLP

San Francisco, California

March 30, 2007